U.S. Stem Cell, Inc. (USRM)
OTCMKTS
· Delayed Price · Currency is USD
0.00
0.00 (0.00%)
At close: Aug 14, 2024
U.S. Stem Cell Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Revenue | 0.08 | 0.08 | 0.2 | 0.28 | 3.07 | 6.7 | Upgrade
|
| Revenue Growth (YoY) | -59.13% | -59.13% | -27.55% | -90.98% | -54.15% | 21.38% | Upgrade
|
| Cost of Revenue | 0.02 | 0.02 | 0.05 | 0.06 | 1.34 | 2.11 | Upgrade
|
| Gross Profit | 0.06 | 0.06 | 0.15 | 0.21 | 1.74 | 4.59 | Upgrade
|
| Selling, General & Admin | 1.78 | 1.78 | 2.28 | 2.61 | 4.45 | 5.68 | Upgrade
|
| Research & Development | - | - | - | - | 0 | 0.01 | Upgrade
|
| Operating Expenses | 1.78 | 1.78 | 2.28 | 2.61 | 4.45 | 5.69 | Upgrade
|
| Operating Income | -1.72 | -1.72 | -2.14 | -2.4 | -2.72 | -1.1 | Upgrade
|
| Interest Expense | -0.69 | -0.69 | -1 | -0.49 | -0.98 | -1.44 | Upgrade
|
| Earnings From Equity Investments | - | - | - | -0.02 | 0.12 | 0.25 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | - | 0.1 | - | Upgrade
|
| EBT Excluding Unusual Items | -2.41 | -2.41 | -3.14 | -2.91 | -3.48 | -2.29 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.02 | 0.13 | 0.13 | Upgrade
|
| Legal Settlements | - | - | - | - | -0.7 | - | Upgrade
|
| Other Unusual Items | -0.45 | -0.45 | -0.15 | 0 | 0.21 | 0.01 | Upgrade
|
| Pretax Income | -2.86 | -2.86 | -3.29 | -2.89 | -3.84 | -2.16 | Upgrade
|
| Net Income | -2.86 | -2.86 | -3.29 | -2.89 | -3.84 | -2.16 | Upgrade
|
| Net Income to Common | -2.86 | -2.86 | -3.29 | -2.89 | -3.84 | -2.16 | Upgrade
|
| Shares Outstanding (Basic) | 592 | 592 | 461 | 429 | 398 | 366 | Upgrade
|
| Shares Outstanding (Diluted) | 592 | 592 | 461 | 429 | 398 | 366 | Upgrade
|
| Shares Change (YoY) | 28.38% | 28.38% | 7.34% | 7.85% | 8.86% | 18.33% | Upgrade
|
| EPS (Basic) | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| EPS (Diluted) | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Free Cash Flow | -0.3 | -0.3 | -1.06 | -0.48 | -1.21 | 0.6 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | Upgrade
|
| Gross Margin | 71.03% | 71.03% | 74.08% | 76.86% | 56.54% | 68.50% | Upgrade
|
| Operating Margin | -2096.90% | -2096.90% | -1063.94% | -866.24% | -88.47% | -16.38% | Upgrade
|
| Profit Margin | -3483.21% | -3483.21% | -1637.58% | -1043.17% | -124.84% | -32.24% | Upgrade
|
| Free Cash Flow Margin | -371.55% | -371.55% | -527.00% | -172.83% | -39.42% | 8.99% | Upgrade
|
| EBITDA | - | - | - | -2.16 | -2.48 | -0.89 | Upgrade
|
| EBITDA Margin | - | - | - | - | -80.57% | -13.29% | Upgrade
|
| D&A For EBITDA | - | - | - | 0.24 | 0.24 | 0.21 | Upgrade
|
| EBIT | -1.72 | -1.72 | -2.14 | -2.4 | -2.72 | -1.1 | Upgrade
|
| EBIT Margin | - | - | - | - | -88.47% | -16.38% | Upgrade
|
| Revenue as Reported | 0.08 | 0.08 | 0.2 | 0.28 | 3.07 | 6.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.